Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
Sponsor: Select Eye Care
You may qualify if…
- ✓ Adult patients of Black African descent scheduled to undergo DSLT treatment in one or both eyes.
- ✓ Diagnosis of mild to moderate primary open angle glaucoma (POAG).
- ✓ Mild to moderate POAG will be defined as Stage 2 or better of the Hodapp-Anderson-Parrish glaucoma staging system.
- ✓ Treatment naive or washed out IOP at time 0 ranging from ≥ 21 through 32 mm Hg.
You may not qualify if…
- ✕ Screened patients who were on IOP-lowering medications who did not successfully complete medication washout at the time of the procedure (time 0).
- ✕ Previous glaucoma surgeries/interventions:
- ✕ Patients who have undergone prior glaucoma-related procedures (e.g., trabeculectomy, laser trabeculoplasty, MIGS, or tube shunt).
- ✕ Secondary glaucoma:
- ✕ Patients with secondary forms of glaucoma, such as angle-closure glaucoma, neovascular glaucoma, or glaucoma resulting from trauma or other systemic diseases.
- ✕ Other significant ocular conditions including advanced cataracts, retinal diseases (e.g., age-related macular degeneration), or any condition that might complicate the assessment of intraocular pressure (IOP) or visual function as deemed by the investigator.
- ✕ Subjects who are pregnant, breast-feeding, or intend to become pregnant during the study period as determined by verbal inquiry.
Where it's recruiting
Elkridge
Source: ClinicalTrials.gov · NCT07147647 · last updated 2025-08-29